Invention Grant
- Patent Title: Aminothiazoles as FBPase inhibitors for diabetes
- Patent Title (中): 氨基噻唑作为糖尿病的FBPase抑制剂
-
Application No.: US12267661Application Date: 2008-11-10
-
Publication No.: US07973051B2Publication Date: 2011-07-05
- Inventor: Paul Hebeisen , Eric A. Kitas , Rudolf E. Minder , Peter Mohr , Hans Peter Wessel
- Applicant: Paul Hebeisen , Eric A. Kitas , Rudolf E. Minder , Peter Mohr , Hans Peter Wessel
- Applicant Address: US NJ Nutley
- Assignee: Hoffman-La Roche Inc.
- Current Assignee: Hoffman-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- Priority: EP07122019 20071130
- Main IPC: A61K31/4365
- IPC: A61K31/4365 ; A61K31/427 ; A61K31/428
Abstract:
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
Public/Granted literature
- US20090143448A1 NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES Public/Granted day:2009-06-04
Information query
IPC分类:
